Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Rangering i aksjer
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Aksjekurs
$8.03
Markedsverdi
$6.31B
Endring (1 dag)
1.07%
Endring (1 år)
-8.04%
Land
CN
Handel Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Kategori
Healthcare
EPS for Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
EPS per June 2026 TTM: $0.33
Ifølge de siste økonomiske rapportene og aksjekursen til Shenzhen New Industries Biomedical Engineering Co., Ltd. er selskapets nåværende EPS (TTM) $0.33. Ved slutten av 2024 hadde selskapet en EPS på $0.32, en økning sammenlignet med EPS-en i 2023 som var $0.30.
EPS-historikk for Shenzhen New Industries Biomedical Engineering Co., Ltd. fra 2012 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $0.33 | 12.55% |
| 2025 | $0.29 | -7.77% |
| 2024 | $0.32 | 7.58% |
| 2023 | $0.30 | 21.10% |
| 2022 | $0.25 | 25.58% |
| 2021 | $0.20 | 1.99% |
| 2020 | $0.19 | 21.08% |
| 2019 | $0.16 | 9.80% |
| 2018 | $0.14 | 23.20% |
| 2017 | $0.12 | 26.68% |
| 2016 | $0.09 | 66.43% |
| 2015 | $0.06 | -7.20% |
| 2014 | $0.06 | 72.54% |
| 2013 | $0.03 | 96.59% |
| 2012 | $0.02 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| $2.70 | 727.21% |
US
|
|
| $4.09 | 1,153.06% |
IE
|
|
| $9.73 | 2,881.00% |
US
|
|
| $2.48 | 659.80% |
US
|
|
| $2.22 | 581.25% |
DE
|
